Connect with us

Headlines

Novartis Acquires Amblyotech

It will continue developing the company’s technology.

mm

Published

on

Novartis announced that it has completed the acquisition of Amblyotech, a U.S.-based software startup and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for treating amblyopia.

Financial terms of the deal were not disclosed.

Designed to enhance compliance, Amblyotech uses active gaming and passive video technology with 3-D glasses, training the eyes to work together to view an image in full, Novartis states in a press release. Its software employs a unique visual presentation, called dichoptic display, where each eye is presented with different images using a proprietary algorithm. In early clinical studies, Amblyotech’s software demonstrated improvements in vision in both children and adults with faster onset compared to standard-of-care treatments.

“By offering a noninvasive solution that has the potential to be significantly faster than current standards of care such as patching for children and adults impacted by lazy eye, Amblyotech’s software is a great example of how we can reimagine medicine using digital technology,” said Nikos Tripodis, global business franchise head, ophthalmology. “We look forward to using our deep clinical development expertise in ophthalmology to accelerate this platform toward regulatory approval, and our global commercial footprint to maximize access for patients who need it.”

With the transaction closing, Novartis plans to work in partnership with video game developer Ubisoft to develop the Amblyotech software as a medical device, create a series of engaging games for the device, and conduct a proof of concept study, planned for later in 2020.

Advertisement

SPONSORED VIDEO

SPONSORED BY ESSILOR

Introducing CrizalⓇ Rock™

Did you know three out of four people wipe their lenses on their clothes?* Or that one out of three people accidentally drop their glasses at least once a week?* It's no surprise, then, that 93 percent of wearers consider scratch-resistance an important characteristic when choosing lenses.* To prove the durability of new Crizal Rock lenses, we ran tests inspired by real life situations. To learn more about new Crizal Rock, the most scratch-resistant Crizal No-Glare lenses ever made, visit EssilorPRO.com/Crizal-Rock. *Study conducted by ⒸIpsos – Risky behaviors of eyeglass wearers - consumer quantitative research 2019 - declarative results - USA - n= 2345 eyeglass wearers

Promoted Headlines

Most Popular